GB201810553D0 - 18F - Fluciclovine compositions in citrate buffers - Google Patents
18F - Fluciclovine compositions in citrate buffersInfo
- Publication number
- GB201810553D0 GB201810553D0 GBGB1810553.6A GB201810553A GB201810553D0 GB 201810553 D0 GB201810553 D0 GB 201810553D0 GB 201810553 A GB201810553 A GB 201810553A GB 201810553 D0 GB201810553 D0 GB 201810553D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- fluciclovine
- compositions
- citrate buffers
- citrate
- buffers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007979 citrate buffer Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0404—Lipids, e.g. triglycerides; Polycationic carriers
- A61K51/0406—Amines, polyamines, e.g. spermine, spermidine, amino acids, (bis)guanidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/001—Acyclic or carbocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Molecular Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1810553.6A GB2561122B (en) | 2012-12-21 | 2012-12-21 | Composition comprising [18F]-Fluciclovine |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1408239.0A GB2509476B (en) | 2011-12-21 | 2012-12-21 | 18F - Fluciclovine compositions in citrate buffers |
GB1810553.6A GB2561122B (en) | 2012-12-21 | 2012-12-21 | Composition comprising [18F]-Fluciclovine |
Publications (3)
Publication Number | Publication Date |
---|---|
GB201810553D0 true GB201810553D0 (en) | 2018-08-15 |
GB2561122A GB2561122A (en) | 2018-10-03 |
GB2561122B GB2561122B (en) | 2019-07-17 |
Family
ID=63143587
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1810553.6A Active GB2561122B (en) | 2012-12-21 | 2012-12-21 | Composition comprising [18F]-Fluciclovine |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2561122B (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2380372T3 (en) * | 2006-05-11 | 2012-05-11 | Nihon Medi-Physics Co., Ltd. | Procedure for the production of radioactive fluorine-labeled organic compound |
EP2119458B9 (en) * | 2007-02-13 | 2013-08-21 | Nihon Medi-Physics Co., Ltd. | Method for production of radiation diagnostic imaging agent |
-
2012
- 2012-12-21 GB GB1810553.6A patent/GB2561122B/en active Active
Also Published As
Publication number | Publication date |
---|---|
GB2561122B (en) | 2019-07-17 |
GB2561122A (en) | 2018-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1210021A1 (en) | Glycoconjugation processes and compositions | |
EP2836212A4 (en) | Novel compositions and methods | |
HK1205751A1 (en) | Conjugates, particles, compositions, and related methods | |
IL235875A0 (en) | Xylitol-based anti-anti-mucosal composition and related methods and compositions | |
ZA201306391B (en) | Nanoparticle compositions | |
PT2793954T (en) | 18f - fluciclovine compositions in citrate buffers | |
GB201209268D0 (en) | Surfactant composition | |
GB201215100D0 (en) | Polymide composition | |
GB201113770D0 (en) | Novel compositions and uses thereof | |
HK1215165A1 (en) | Compositions | |
GB201315350D0 (en) | Methods and compositions | |
EP2668044A4 (en) | Compositions and their use | |
ZA201308892B (en) | Compositions and methods | |
GB201315347D0 (en) | Methods and compositions | |
EP2874641A4 (en) | Glutathione-elevating compositions and uses thereof | |
GB201201287D0 (en) | Compositions | |
GB201106357D0 (en) | Composition and uses thereof | |
EP2819668A4 (en) | Ritonavir compositions | |
IL232397A (en) | 18f-fluciclovine compositions in citrate buffers | |
SI2830587T1 (en) | Dermo-protective and dermo-balancing composition | |
GB201810553D0 (en) | 18F - Fluciclovine compositions in citrate buffers | |
ZA201404932B (en) | 18f-fluciclovine compositions in citrate buffers | |
GB201107454D0 (en) | Compositions and uses | |
GB201101924D0 (en) | Compositions and uses | |
GB201120470D0 (en) | Compositions and uses thereof |